Back to top

messenger-rna: Archive

Zacks Equity Research

Moderna Stock Jumps After FDA Reverses Course on Flu Shot

MRNA stock rises 6% as the FDA agrees to review its flu vaccine filing after a surprise reversal, with a decision expected by Aug. 5, 2026.

SNYPositive Net Change GSKPositive Net Change MRNAPositive Net Change